[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11201501800UA - C17-heteroaryl derivatives of oleanolic acid and methods of use thereof - Google Patents

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

Info

Publication number
SG11201501800UA
SG11201501800UA SG11201501800UA SG11201501800UA SG11201501800UA SG 11201501800U A SG11201501800U A SG 11201501800UA SG 11201501800U A SG11201501800U A SG 11201501800UA SG 11201501800U A SG11201501800U A SG 11201501800UA SG 11201501800U A SG11201501800U A SG 11201501800UA
Authority
SG
Singapore
Prior art keywords
methods
oleanolic acid
heteroaryl derivatives
heteroaryl
derivatives
Prior art date
Application number
SG11201501800UA
Other languages
English (en)
Inventor
Xin Jiang
Christopher F Bender
Melean Visnick
Original Assignee
Reata Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc
Publication of SG11201501800UA publication Critical patent/SG11201501800UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Epidemiology (AREA)
SG11201501800UA 2012-09-10 2013-09-10 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof SG11201501800UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261699199P 2012-09-10 2012-09-10
PCT/US2013/059015 WO2014040056A1 (en) 2012-09-10 2013-09-10 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

Publications (1)

Publication Number Publication Date
SG11201501800UA true SG11201501800UA (en) 2015-04-29

Family

ID=49253401

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501800UA SG11201501800UA (en) 2012-09-10 2013-09-10 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

Country Status (28)

Country Link
US (1) US20140088163A1 (pt)
EP (1) EP2892911B1 (pt)
JP (1) JP6272870B2 (pt)
KR (1) KR102237364B1 (pt)
CN (1) CN104768965B (pt)
AU (1) AU2013312102B2 (pt)
BR (1) BR112015005200B1 (pt)
CA (1) CA2882417C (pt)
CY (1) CY1119762T1 (pt)
DK (1) DK2892911T3 (pt)
EA (1) EA029069B1 (pt)
ES (1) ES2644615T3 (pt)
HK (1) HK1211295A1 (pt)
HR (1) HRP20171565T1 (pt)
HU (1) HUE036797T2 (pt)
IL (1) IL237638B (pt)
IN (1) IN2015DN01547A (pt)
LT (1) LT2892911T (pt)
ME (1) ME02911B (pt)
MX (1) MX366954B (pt)
NZ (1) NZ705213A (pt)
PL (1) PL2892911T3 (pt)
PT (1) PT2892911T (pt)
RS (1) RS56563B1 (pt)
SG (1) SG11201501800UA (pt)
SI (1) SI2892911T1 (pt)
WO (1) WO2014040056A1 (pt)
ZA (1) ZA201501203B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2252283T1 (sl) 2008-01-11 2019-02-28 Reata Pharmaceuticals, Inc. Sintetični triterpenoidi in postopki uporabe pri zdravljenju bolezni
SG190564A1 (en) 2008-04-18 2013-06-28 Reata Pharmaceuticals Inc Compounds including an anti-inflammatory pharmacore and methods of use
CA2721838C (en) 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
EA025568B1 (ru) 2010-12-17 2017-01-30 Рита Фармасьютикалз, Инк. Пиразолильные и пиримидинильные трициклические еноны в качестве антиоксидантных модуляторов воспаления
PL3444261T3 (pl) 2012-04-27 2021-07-19 Reata Pharmaceuticals, Inc. Pochodne 2,2-difluoropropionamidowe bardoksolonu metylu, ich kompozycje farmaceutyczne i formy polimorficzne do zastosowania w leczeniu określonych stanów
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
DK2892912T3 (da) 2012-09-10 2019-06-24 Reata Pharmaceuticals Inc C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
UY35534A (es) 2013-04-24 2014-10-31 Abbvie Inc Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
CA2974726C (en) 2015-02-12 2023-09-19 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant inflammation modulators
JP7074674B2 (ja) 2015-09-23 2022-05-24 リアタ ファーマシューティカルズ インコーポレイテッド Il-17の阻害及び他の使用のためのc4修飾オレアノール酸誘導体
WO2019055119A1 (en) 2017-09-14 2019-03-21 Phoenix Biotechnology, Inc. METHOD AND COMPOSITION FOR TREATING VIRAL INFECTION
KR102486434B1 (ko) 2016-11-08 2023-01-09 리아타 파마슈티컬즈 홀딩스, 엘엘씨 바독솔론 메틸 또는 이의 유사체를 사용하는 알포트 증후군의 치료 방법
CN106632574B (zh) * 2016-12-07 2018-05-29 广东天键生物科技有限公司 一种化合物、其制备方法及用途
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
EP3681477A4 (en) 2017-09-14 2021-06-09 Phoenix Biotechnology, Inc. IMPROVED METHOD AND COMPOSITION FOR THE TREATMENT OF CONDITIONS, DISEASES OR DISORDERS SENSITIVE TO TRITERPENES
KR20210032936A (ko) 2018-06-15 2021-03-25 리아타 파마슈티컬즈, 아이엔씨. Il-17 및 ror감마의 저해를 위한 피라졸 및 이미다졸 화합물
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
BR112021005919A2 (pt) * 2018-09-28 2021-07-27 Sichuan Haisco Pharmaceutical Co., Ltd. composto, composição farmacêutica e método para tratar uma doença em um mamífero
CA3144603A1 (en) * 2019-07-19 2021-01-28 Xin Jiang C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
EP4295854A3 (en) 2020-03-31 2024-04-03 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
MX2020009095A (es) 2020-03-31 2022-07-28 Phoenix Biotechnology Inc Metodo y composiciones para el tratamiento de infeccion por coronavirus.
JP7214696B2 (ja) * 2020-10-01 2023-01-30 一般財団法人 化学物質評価研究機構 新規in vitro皮膚感作性試験法
EP4259155A1 (en) 2020-12-11 2023-10-18 Reata Pharmaceuticals Holdings, LLC Synthetic triterpenoids for use in therapy
PE20231661A1 (es) 2021-01-18 2023-10-17 Reata Pharmaceuticals Inc Derivados de acido ursolico sinteticos y metodos de uso de los mismos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
CA2485565A1 (en) * 2002-05-13 2004-08-05 Trustees Of Dartmouth College Inhibitors and methods of use thereof
SI2252283T1 (sl) 2008-01-11 2019-02-28 Reata Pharmaceuticals, Inc. Sintetični triterpenoidi in postopki uporabe pri zdravljenju bolezni
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CN102066398B (zh) * 2008-04-18 2014-09-10 里亚塔医药公司 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物
US7915402B2 (en) * 2008-04-18 2011-03-29 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
CA2721838C (en) 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
PL2683731T3 (pl) * 2011-03-11 2019-09-30 Reata Pharmaceuticals, Inc. C4-monometylowe pochodne triterpenoidów i sposoby ich zastosowania
US9556222B2 (en) * 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

Also Published As

Publication number Publication date
EP2892911A1 (en) 2015-07-15
ZA201501203B (en) 2021-08-25
IL237638B (en) 2020-04-30
MX2015003078A (es) 2015-07-14
IL237638A0 (en) 2015-04-30
AU2013312102A1 (en) 2015-03-12
HRP20171565T1 (hr) 2017-12-15
NZ705213A (en) 2018-07-27
CA2882417A1 (en) 2014-03-13
DK2892911T3 (en) 2017-10-23
US20140088163A1 (en) 2014-03-27
CN104768965A (zh) 2015-07-08
KR102237364B1 (ko) 2021-04-06
EA029069B1 (ru) 2018-02-28
BR112015005200A2 (pt) 2017-08-15
PL2892911T3 (pl) 2018-03-30
PT2892911T (pt) 2017-11-02
JP6272870B2 (ja) 2018-01-31
CY1119762T1 (el) 2018-06-27
BR112015005200B1 (pt) 2022-07-05
KR20150053982A (ko) 2015-05-19
ES2644615T3 (es) 2017-11-29
MX366954B (es) 2019-07-31
CN104768965B (zh) 2018-05-11
EP2892911B1 (en) 2017-08-30
ME02911B (me) 2018-10-20
HUE036797T2 (hu) 2018-07-30
RS56563B1 (sr) 2018-02-28
WO2014040056A1 (en) 2014-03-13
IN2015DN01547A (pt) 2015-07-03
CA2882417C (en) 2021-04-20
HK1211295A1 (en) 2016-05-20
AU2013312102B2 (en) 2018-03-08
SI2892911T1 (sl) 2017-12-29
EA201590539A1 (ru) 2015-08-31
LT2892911T (lt) 2017-11-10
JP2015529227A (ja) 2015-10-05

Similar Documents

Publication Publication Date Title
HK1211295A1 (en) C17-heteroaryl derivatives of oleanolic acid and methods of use thereof c17-
HK1212355A1 (en) C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof c17-
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
SI2683731T1 (sl) C4-monometil triterpenoidni derivati in postopki njihove uporabe
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
HK1212977A1 (zh) 苯達莫司汀衍生物及其使用方法
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
EP2986112A4 (en) PREPARATION AND USE OF FULVINIC ACID DERIVATIVES
ZA201408128B (en) Etract of greyia radlkoferi and use thereof